Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGND) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Ligand Pharmaceuticals (LGND) over the last 16 years, with Q3 2025 value amounting to 60.36.

  • Ligand Pharmaceuticals' Interest Coverage Ratio rose 132314.76% to 60.36 in Q3 2025 from the same period last year, while for Sep 2025 it was 4.6, marking a year-over-year increase of 16420.01%. This contributed to the annual value of 7.44 for FY2024, which is 14088.89% down from last year.
  • According to the latest figures from Q3 2025, Ligand Pharmaceuticals' Interest Coverage Ratio is 60.36, which was up 132314.76% from 7.32 recorded in Q2 2025.
  • In the past 5 years, Ligand Pharmaceuticals' Interest Coverage Ratio registered a high of 3078.0 during Q3 2023, and its lowest value of 83.75 during Q4 2022.
  • Over the past 5 years, Ligand Pharmaceuticals' median Interest Coverage Ratio value was 4.24 (recorded in 2024), while the average stood at 164.63.
  • Per our database at Business Quant, Ligand Pharmaceuticals' Interest Coverage Ratio crashed by 109210.7% in 2022 and then skyrocketed by 818049.59% in 2023.
  • Quarter analysis of 5 years shows Ligand Pharmaceuticals' Interest Coverage Ratio stood at 8.44 in 2021, then tumbled by 1092.11% to 83.75 in 2022, then skyrocketed by 69.39% to 25.63 in 2023, then soared by 57.42% to 10.91 in 2024, then surged by 653.09% to 60.36 in 2025.
  • Its Interest Coverage Ratio stands at 60.36 for Q3 2025, versus 7.32 for Q2 2025 and 41.77 for Q1 2025.